Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (81-90 of 442) with videos related to

Pageof 45
Sort By:
Transplantation and Cellular Therapy|May 9, 2021
Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAndreas Rank, Christophe Peczynski, Myriam Labopin, et al.
British Journal of Haematology|October 16, 2019
Graft-versus-host disease and graft-versus-leukaemia effects in secondary acute myeloid leukaemia: a retrospective, multicentre registry analysis from the Acute Leukaemia Working Party of the EBMTFrédéric Baron, Myriam Labopin, Bipin N Savani, et al.
Cancer|January 24, 2018
Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamideAnnalisa Ruggeri, Myriam Labopin, Andrea Bacigalupo, et al.
Leukemia|June 17, 2018
Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamideAvichai Shimoni, Myriam Labopin, Francesca Lorentino, et al.
Blood|September 17, 2013
CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMTMartin Schmidt-Hieber, Myriam Labopin, Dietrich Beelen, et al.
Haematologica|April 16, 2016
Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemiaCharles Craddock, Myriam Labopin, Marie Robin, et al.
Bone Marrow Transplantation|September 29, 2019
Pre-emptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomesNicolas Stocker, Myriam Labopin, Inès Boussen, et al.
American Journal of Hematology|April 4, 2017
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMTJonathan Canaani, Myriam Labopin, Gerard Socié, et al.
Cancer|October 7, 2014
Reduced-toxicity conditioning with fludarabine, once-daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: results of a multicenter prospective phase 2 trialMohamad Mohty, Florent Malard, Didier Blaise, et al.
Bone Marrow Transplantation|January 13, 2022
The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AMLAvichai Shimoni, Myriam Labopin, Emanuele Angelucci, et al.
Pageof 45

Showing results (81-90 of 442) with videos related to

Sort By:
Pageof 45
Transplantation and Cellular Therapy|May 9, 2021
Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAndreas Rank, Christophe Peczynski, Myriam Labopin, et al.
British Journal of Haematology|October 16, 2019
Graft-versus-host disease and graft-versus-leukaemia effects in secondary acute myeloid leukaemia: a retrospective, multicentre registry analysis from the Acute Leukaemia Working Party of the EBMTFrédéric Baron, Myriam Labopin, Bipin N Savani, et al.
Cancer|January 24, 2018
Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamideAnnalisa Ruggeri, Myriam Labopin, Andrea Bacigalupo, et al.
Leukemia|June 17, 2018
Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamideAvichai Shimoni, Myriam Labopin, Francesca Lorentino, et al.
Blood|September 17, 2013
CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMTMartin Schmidt-Hieber, Myriam Labopin, Dietrich Beelen, et al.
Haematologica|April 16, 2016
Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemiaCharles Craddock, Myriam Labopin, Marie Robin, et al.
Bone Marrow Transplantation|September 29, 2019
Pre-emptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomesNicolas Stocker, Myriam Labopin, Inès Boussen, et al.
American Journal of Hematology|April 4, 2017
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMTJonathan Canaani, Myriam Labopin, Gerard Socié, et al.
Cancer|October 7, 2014
Reduced-toxicity conditioning with fludarabine, once-daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: results of a multicenter prospective phase 2 trialMohamad Mohty, Florent Malard, Didier Blaise, et al.
Bone Marrow Transplantation|January 13, 2022
The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AMLAvichai Shimoni, Myriam Labopin, Emanuele Angelucci, et al.
Pageof 45